First Time Loading...

Solasia Pharma KK
TSE:4597

Watchlist Manager
Solasia Pharma KK Logo
Solasia Pharma KK
TSE:4597
Watchlist
Price: 26 JPY 4% Market Closed
Updated: Apr 28, 2024

Intrinsic Value

Solasia Pharma KK's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Solasia Pharma KK engages in the development, sale, import and export of pharmaceutical products and medical devices. [ Read More ]

The intrinsic value of one Solasia Pharma KK stock under the Base Case scenario is 37.13 JPY. Compared to the current market price of 26 JPY, Solasia Pharma KK is Undervalued by 30%.

Key Points:
Intrinsic Value
Base Case
37.13 JPY
Undervaluation 30%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Solasia Pharma KK

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Solasia Pharma KK stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Solasia Pharma KK

Provide an overview of the primary business activities
of Solasia Pharma KK.

What unique competitive advantages
does Solasia Pharma KK hold over its rivals?

What risks and challenges
does Solasia Pharma KK face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Solasia Pharma KK.

Provide P/S
for Solasia Pharma KK.

Provide P/E
for Solasia Pharma KK.

Provide P/OCF
for Solasia Pharma KK.

Provide P/FCFE
for Solasia Pharma KK.

Provide P/B
for Solasia Pharma KK.

Provide EV/S
for Solasia Pharma KK.

Provide EV/GP
for Solasia Pharma KK.

Provide EV/EBITDA
for Solasia Pharma KK.

Provide EV/EBIT
for Solasia Pharma KK.

Provide EV/OCF
for Solasia Pharma KK.

Provide EV/FCFF
for Solasia Pharma KK.

Provide EV/IC
for Solasia Pharma KK.

Show me price targets
for Solasia Pharma KK made by professional analysts.

What are the Revenue projections
for Solasia Pharma KK?

How accurate were the past Revenue estimates
for Solasia Pharma KK?

What are the Net Income projections
for Solasia Pharma KK?

How accurate were the past Net Income estimates
for Solasia Pharma KK?

What are the EPS projections
for Solasia Pharma KK?

How accurate were the past EPS estimates
for Solasia Pharma KK?

What are the EBIT projections
for Solasia Pharma KK?

How accurate were the past EBIT estimates
for Solasia Pharma KK?

Compare the revenue forecasts
for Solasia Pharma KK with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Solasia Pharma KK and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Solasia Pharma KK against its competitors.

Analyze the profit margins
(gross, operating, and net) of Solasia Pharma KK compared to its peers.

Compare the P/E ratios
of Solasia Pharma KK against its peers.

Discuss the investment returns and shareholder value creation
comparing Solasia Pharma KK with its peers.

Analyze the financial leverage
of Solasia Pharma KK compared to its main competitors.

Show all profitability ratios
for Solasia Pharma KK.

Provide ROE
for Solasia Pharma KK.

Provide ROA
for Solasia Pharma KK.

Provide ROIC
for Solasia Pharma KK.

Provide ROCE
for Solasia Pharma KK.

Provide Gross Margin
for Solasia Pharma KK.

Provide Operating Margin
for Solasia Pharma KK.

Provide Net Margin
for Solasia Pharma KK.

Provide FCF Margin
for Solasia Pharma KK.

Show all solvency ratios
for Solasia Pharma KK.

Provide D/E Ratio
for Solasia Pharma KK.

Provide D/A Ratio
for Solasia Pharma KK.

Provide Interest Coverage Ratio
for Solasia Pharma KK.

Provide Altman Z-Score Ratio
for Solasia Pharma KK.

Provide Quick Ratio
for Solasia Pharma KK.

Provide Current Ratio
for Solasia Pharma KK.

Provide Cash Ratio
for Solasia Pharma KK.

What is the historical Revenue growth
over the last 5 years for Solasia Pharma KK?

What is the historical Net Income growth
over the last 5 years for Solasia Pharma KK?

What is the current Free Cash Flow
of Solasia Pharma KK?

Discuss the annual earnings per share (EPS)
trend over the past five years for Solasia Pharma KK.

Financials

Balance Sheet Decomposition
Solasia Pharma KK

Current Assets 976m
Cash & Short-Term Investments 728m
Receivables 67m
Other Current Assets 181m
Non-Current Assets 1.3B
Long-Term Investments 6m
PP&E 81m
Intangibles 1.1B
Other Non-Current Assets 49m
Current Liabilities 293m
Accounts Payable 213m
Other Current Liabilities 80m
Non-Current Liabilities 61m
Long-Term Debt 27m
Other Non-Current Liabilities 34m
Efficiency

Earnings Waterfall
Solasia Pharma KK

Revenue
617m JPY
Cost of Revenue
-280m JPY
Gross Profit
337m JPY
Operating Expenses
-1.5B JPY
Operating Income
-1.1B JPY
Other Expenses
27m JPY
Net Income
-1.1B JPY

Free Cash Flow Analysis
Solasia Pharma KK

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

Solasia Pharma KK's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

26/100
Profitability
Score

Solasia Pharma KK's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Solasia Pharma KK's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Negative Net Debt
Low D/E
86/100
Solvency
Score

Solasia Pharma KK's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Solasia Pharma KK

Wall Street analysts forecast Solasia Pharma KK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Solasia Pharma KK is 86.7 JPY with a low forecast of 85.85 JPY and a high forecast of 89.25 JPY.

Lowest
Price Target
85.85 JPY
230% Upside
Average
Price Target
86.7 JPY
233% Upside
Highest
Price Target
89.25 JPY
243% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Solasia Pharma KK

1M 1M
-19%
6M 6M
-32%
1Y 1Y
-43%
3Y 3Y
-82%
5Y 5Y
-86%
10Y 10Y
-90%
Annual Price Range
26
52w Low
25
52w High
69
Price Metrics
Average Annual Return -25.92%
Standard Deviation of Annual Returns 23.74%
Max Drawdown -89%
Shares Statistics
Market Capitalization 4.5B JPY
Shares Outstanding 181 693 090
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Solasia Pharma KK Logo
Solasia Pharma KK

Country

Japan

Industry

Biotechnology

Market Cap

4.5B JPY

Dividend Yield

0%

Description

Solasia Pharma KK engages in the development, sale, import and export of pharmaceutical products and medical devices. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 77 full-time employees. The company went IPO on 2017-03-24. is a Japan-based pharmaceutical company. The firm is mainly engaged in the development, sale, importing and exporting of pharmaceutical products targeting commercialization in Japan, China and other Asian countries. The company focuses on commercializing assets in the oncology/hematology field, by developing products licensed from western pharmaceutical and biotech companies. The firm's main products include SP-01 Granisetron Transdermal Delivery System (Sancuso), SP-02 Darinaparsin (Zinapar, ZIO-101, and SP-03 Oral Medical Device (episil oral liquid).

Contact

TOKYO-TO
Minato-ku
4F, Sumitomo Fudosan Shibakoen Tower, 2-11-1, Shibakoen
+81358438045.0
http://solasia.co.jp/

IPO

2017-03-24

Employees

77

Officers

President, CEO & Representative Director
Mr. Yoshihiro Arai
CFO, GM of Management Headquarters & Director
Mr. Toshio Miyashita
Accounting Manager
Yasumitsu Shimada
Head of Marketing Division
Yasuaki Manabe
Head of Business Development Department
Mr. Koji Shinozaki
Head of Product Development Division
Fumiko Nagahama
Show More
Head of Production Management Division
Hikaru Osawa
Head of Reliability Assurance Division
Wataru Kobayashi
Show Less

See Also

Discover More
What is the Intrinsic Value of one Solasia Pharma KK stock?

The intrinsic value of one Solasia Pharma KK stock under the Base Case scenario is 37.13 JPY.

Is Solasia Pharma KK stock undervalued or overvalued?

Compared to the current market price of 26 JPY, Solasia Pharma KK is Undervalued by 30%.